I
0.602
-0.01 (-1.21%)
| Previous Close | 0.610 |
| Open | 0.600 |
| Volume | 662,767 |
| Avg. Volume (3M) | 624,812 |
| Market Cap | 33,434,164 |
| Price / Sales | 8.55 |
| Price / Book | 2.85 |
| 52 Weeks Range |
| Operating Margin (TTM) | -319.29% |
| Diluted EPS (TTM) | -0.290 |
| Quarterly Revenue Growth (YOY) | 7.90% |
| Total Debt/Equity (MRQ) | 4.90% |
| Current Ratio (MRQ) | 2.97 |
| Operating Cash Flow (TTM) | -10.83 M |
| Levered Free Cash Flow (TTM) | -6.62 M |
| Return on Assets (TTM) | -47.36% |
| Return on Equity (TTM) | -94.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Mixed |
| Medical Devices (Global) | Mixed | Mixed | |
| Stock | IceCure Medical Ltd. | Mixed | Bearish |
Stockmoo Score
1.0
| Analyst Consensus | 2.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 3.5 |
| Technical Oscillators | -2.5 |
| Average | 1.00 |
|
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Value |
| % Held by Insiders | 54.18% |
| % Held by Institutions | 0.42% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Virtu Financial Llc | 30 Jun 2024 | 27,189 |
| Concurrent Investment Advisors, Llc | 30 Sep 2024 | 10,000 |
| Foundations Investment Advisors, Llc | 30 Sep 2024 | 10,000 |
| Avion Wealth | 30 Sep 2024 | 2,500 |
| Royal Bank Of Canada | 30 Sep 2024 | 1,087 |
| Bartlett & Co. Llc | 31 Dec 2023 | 250 |
| 52 Weeks Range | ||
| Median | 2.50 (315.01%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 08 Nov 2024 | 2.50 (315.01%) | Buy | 0.653 |
| 12 Sep 2024 | 2.50 (315.01%) | Buy | 0.630 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |